Eli Lilly and Company (SWX:LLY)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
625.00
+10.00 (1.63%)
At close: Jun 4, 2025
-15.54%
Market Cap 563.68B
Revenue (ttm) 43.32B
Net Income (ttm) 9.82B
Shares Out n/a
EPS (ttm) 10.86
PE Ratio 57.42
Forward PE 30.49
Dividend 4.89 (0.78%)
Ex-Dividend Date May 16, 2025
Volume n/a
Average Volume 3
Open n/a
Previous Close 615.00
Day's Range n/a
52-Week Range 540.00 - 833.88
Beta 0.33
RSI 52.08
Earnings Date Aug 7, 2025

About Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Ja... [Read more]

Industry Drug Manufacturers - General
Sector Healthcare
Founded 1876
Employees 47,000
Stock Exchange SIX Swiss Exchange
Ticker Symbol LLY
Full Company Profile

Financial Performance

In 2024, Eli Lilly and Company's revenue was $45.04 billion, an increase of 32.00% compared to the previous year's $34.12 billion. Earnings were $10.59 billion, an increase of 102.08%.

Financial numbers in USD Financial Statements

News

Lilly's Jake Van Naarden: Lilly's success with GLP-1's allows us to reinvest in oncology

CNBC's Angelica Peebles sits down with Lilly's Head of Oncology, Jake Van Naarden, to discuss what's next in Lilly's oncology pipeline and what Lilly is changing about its clinical trials to make them...

19 hours ago - CNBC Television

Welldoc Works with Lilly to Launch a New Personalized Health & Medicine Platform for Those Prescribed Lilly's Incretin Therapies

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered digital health innovation, today announced it will power the newly launched Lilly Health™ Personalized Health & Medicine Platform* (Lil...

1 day ago - Business Wire

TGA approves weight-loss drug to treat sleep disorder

The medicines regulator has approved Eli Lilly’s Mounjaro weight-loss drug to be used to treat sleep apnoea.

2 days ago - The Australian Financial Review

Here's what is driving Tuesday's stock rally plus, an analyst comes to Eli Lilly's defense

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

2 days ago - CNBC

Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins

Partnership focused on development of long-acting therapies based on Camurus' FluidCrystal® technology and Eli Lilly's proprietary drug compounds Camurus eligible to receive up to $870 million in pote...

2 days ago - PRNewsWire

Top 50 High-Quality Dividend Stocks For June 2025

I track 50 high-quality dividend growth stocks to identify opportune investments, updating valuation ratings daily to focus on attractive opportunities. In this turbulent year, my investable universe ...

2 days ago - Seeking Alpha

LLY Stock Too Cheap At $750?

Question: Why would you pay 81 times earnings for AbbVie stock when you can buy LLY for a similar valuation of 76 times earnings? You wouldn't, especially when you consider three simple facts:

2 days ago - Forbes

Biotech Bull Case, ABVX International Interest, JNJ & LLY Options Trades

"You cannot not believe in science," says Tsvetta Kaleynska. She sees biotech companies outperforming in 2025 despite a slow start to the year.

3 days ago - Schwab Network

Tech sector tumbles: Healthcare stocks shine amid market volatility

📈 Sector Overview Today's stock market heatmap reveals a dynamic yet volatile landscape, with technology stocks experiencing notable declines while the healthcare sector exhibits significant resilien...

3 days ago - Forexlive

Lilly to participate in Goldman Sachs 46th Annual Global Health Care Conference

INDIANAPOLIS , June 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Goldman Sachs 46th Annual Global Health Care Conference on June 10, 2025. Lucas Montarce, Lilly exe...

3 days ago - PRNewsWire

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting

INDIANAPOLIS , June 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its folate receptor alpha (FRα) antibody-drug conjugate (ADC) (LY4170156) de...

3 days ago - PRNewsWire

Eli Lilly Rises 1.5% After Key Trading Signal

TradePulse Alert Confirms Early Up Move in LLY Eli Lilly (LLY) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their...

3 days ago - Benzinga

Eli Lilly Rises 1.5% After Key Trading Signal

TradePulse Alert Confirms Early Up Move in LLY

3 days ago - Benzinga

Tech stocks struggle while healthcare gains: Today's market overview

Tech stocks struggle while healthcare gains: Today's market overview The US stock market is showcasing a dynamic landscape today, characterized by struggles within the semiconductor sector and encoura...

6 days ago - Forexlive

5 Alpha Generating Monsters

Any stock can generate alpha, but doing it consistently is rare. These 5 stocks have delivered alpha for 4 out of the last 5 years. Valuation is important, so I screen for it and eliminate overpriced ...

6 days ago - Seeking Alpha

Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions

INDIANAPOLIS , May 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatr...

7 days ago - PRNewsWire

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

7 days ago - Investor's Business Daily